69 related articles for article (PubMed ID: 28401017)
1. miR-495 promotes the chemoresistance of SCLC through the epithelial-mesenchymal transition via Etk/BMX.
Wei T; Zhu W; Fang S; Zeng X; Huang J; Yang J; Zhang J; Guo L
Am J Cancer Res; 2017; 7(3):628-646. PubMed ID: 28401017
[TBL] [Abstract][Full Text] [Related]
2. HMGB1 promotes chemoresistance in small cell lung cancer by inducing PARP1-related nucleophagy.
Shen W; Lyu Q; Yi R; Sun Y; Zhang W; Wei T; Zhang Y; Shi J; Zhang J
J Adv Res; 2023 Dec; ():. PubMed ID: 38159843
[TBL] [Abstract][Full Text] [Related]
3. Structural and biophysical insights into the mode of covalent binding of rationally designed potent BMX inhibitors.
Seixas JD; Sousa BB; Marques MC; Guerreiro A; Traquete R; Rodrigues T; Albuquerque IS; Sousa MFQ; Lemos AR; Sousa PMF; Bandeiras TM; Wu D; Doyle SK; Robinson CV; Koehler AN; Corzana F; Matias PM; Bernardes GJL
RSC Chem Biol; 2020 Oct; 1(4):251-262. PubMed ID: 34458764
[TBL] [Abstract][Full Text] [Related]
4. AI & experimental-based discovery and preclinical IND-enabling studies of selective BMX inhibitors for development of cancer therapeutics.
Elsanhoury R; Alasmari A; Parupathi P; Jumaa M; Al-Fayoumi S; Kumar A; Khashan R; Nazzal S; Fayyad AA
Int J Pharm; 2023 Oct; 645():123384. PubMed ID: 37678472
[TBL] [Abstract][Full Text] [Related]
5. Ras homolog family member J (RHOJ): a key regulator of chemoresistance associated with epithelial-mesenchymal transition.
Liu S; Ren J; Zhang L
Signal Transduct Target Ther; 2023 Oct; 8(1):376. PubMed ID: 37779170
[No Abstract] [Full Text] [Related]
6. Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression.
Zeng F; Wang Q; Wang S; Liang S; Huang W; Guo Y; Peng J; Li M; Zhu W; Guo L
Oncogene; 2020 Jan; 39(2):293-307. PubMed ID: 31477834
[TBL] [Abstract][Full Text] [Related]
7. BMX-Mediated Regulation of Multiple Tyrosine Kinases Contributes to Castration Resistance in Prostate Cancer.
Chen S; Cai C; Sowalsky AG; Ye H; Ma F; Yuan X; Simon NI; Gray NS; Balk SP
Cancer Res; 2018 Sep; 78(18):5203-5215. PubMed ID: 30012673
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemia.
van Oosterwijk JG; Buelow DR; Drenberg CD; Vasilyeva A; Li L; Shi L; Wang YD; Finkelstein D; Shurtleff SA; Janke LJ; Pounds S; Rubnitz JE; Inaba H; Pabla N; Baker SD
J Clin Invest; 2018 Jan; 128(1):369-380. PubMed ID: 29227282
[TBL] [Abstract][Full Text] [Related]
9. BMX/Etk promotes cell proliferation and tumorigenicity of cervical cancer cells through PI3K/AKT/mTOR and STAT3 pathways.
Li Y; Cui N; Zheng PS; Yang WT
Oncotarget; 2017 Jul; 8(30):49238-49252. PubMed ID: 28514765
[TBL] [Abstract][Full Text] [Related]
10. Non-Coding RNAs as Key Regulators in Lung Cancer.
Gilyazova I; Gimalova G; Nizamova A; Galimova E; Ishbulatova E; Pavlov V; Khusnutdinova E
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203731
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-495: a therapeutic and diagnostic tumor marker.
Maharati A; Tolue Ghasaban F; Akhlaghipour I; Taghehchian N; Zangouei AS; Moghbeli M
J Mol Histol; 2023 Dec; 54(6):559-578. PubMed ID: 37759132
[TBL] [Abstract][Full Text] [Related]
12. Repression of linc01555 up-regulates angiomotin-p130 via the microRNA-122-5p/clic1 axis to impact vasculogenic mimicry-mediated chemotherapy resistance in small cell lung cancer.
Li D; Shen Y; Ren H; Wang L; Yang J; Wang Y
Cell Cycle; 2023 Jan; 22(2):255-268. PubMed ID: 36045598
[TBL] [Abstract][Full Text] [Related]
13. Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian.
Lin A; Zhou N; Zhu W; Zhang J; Wei T; Guo L; Luo P; Zhang J
Cancer Cell Int; 2022 Apr; 22(1):173. PubMed ID: 35488336
[TBL] [Abstract][Full Text] [Related]
14. TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.
Lin A; Zhang H; Meng H; Deng Z; Gu T; Luo P; Zhang J
Front Immunol; 2021; 12():667875. PubMed ID: 34603277
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs Involved in Small-cell Lung Cancer as Possible Agents for Treatment and Identification of New Targets.
Weidle UH; Nopora A
Cancer Genomics Proteomics; 2021; 18(5):591-603. PubMed ID: 34479913
[TBL] [Abstract][Full Text] [Related]
16. EMT-associated microRNAs and their roles in cancer stemness and drug resistance.
Pan G; Liu Y; Shang L; Zhou F; Yang S
Cancer Commun (Lond); 2021 Mar; 41(3):199-217. PubMed ID: 33506604
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-495 enhances chondrocyte apoptosis, senescence and promotes the progression of osteoarthritis by targeting AKT1.
Zhao X; Wang T; Cai B; Wang X; Feng W; Han Y; Li D; Li S; Liu J
Am J Transl Res; 2019; 11(4):2232-2244. PubMed ID: 31105831
[TBL] [Abstract][Full Text] [Related]
18. Are there any theranostic biomarkers in small cell lung carcinoma?
Pezzuto F; Fortarezza F; Lunardi F; Calabrese F
J Thorac Dis; 2019 Jan; 11(Suppl 1):S102-S112. PubMed ID: 30775033
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Ipilimumab plus Chemotherapy for Advanced Lung Cancer: A Systematic Review and Meta-Analysis.
Zhang H; Shen J; Yi L; Zhang W; Luo P; Zhang J
J Cancer; 2018; 9(23):4556-4567. PubMed ID: 30519362
[TBL] [Abstract][Full Text] [Related]
20. [miR-203 inhibits lung cancer cell metastasis by targeting fatty acid binding protein 4].
Chen JC; Wu X
Nan Fang Yi Ke Da Xue Xue Bao; 2018 May; 38(5):578-583. PubMed ID: 29891455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
